Answers are grounded in this paper and cite their sources.
Observational analysis reveals reduced prognosis in patients with transthyretin amyloidosis cardiomyopathy after rehabilitation.
[Purpose] This study aimed to investigate the changes in physical function during hospitalization and their impact on the outcomes of patients with transthyretin amyloidosis cardiomyopathy who experienced acute decompensated heart failure and underwent acute cardiac rehabilitation. [Participants and Methods] A matched cohort of 18 and 54 patients with and without transthyretin amyloidosis cardiomyopathy, respectively, was created and analyzed. [Results] Compared to patients without transthyretin amyloidosis cardiomyopathy, those with transthyretin amyloidosis showed similar improvements in grip strength, quadriceps isometric strength, short physical performance battery, and usual gait speed during hospitalization. However, transthyretin amyloidosis cardiomyopathy was associated with a significantly increased risk of both rehospitalization due to heart failure and all-cause mortality. [Conclusion] Although the extent of changes in physical function during hospitalization was similar in patients with and without transthyretin amyloidosis cardiomyopathy, transthyretin amyloidosis cardiomyopathy was associated with poorer outcomes.
No takes yet. Share an insight, caveat, or question.
Nakaya et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: